Anthony Clarke
2019
In 2019, Anthony Clarke earned a total compensation of $589.7K as President and Chief Scientific Officer at OncoGenex Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,000 |
|---|---|
| Option Awards | $43,657 |
| Salary | $420,000 |
| Total | $589,657 |
Clarke received $420K in salary, accounting for 71% of the total pay in 2019.
Clarke also received $126K in non-equity incentive plan and $43.7K in option awards.
Rankings
In 2019, Anthony Clarke's compensation ranked 11,263rd out of 13,971 executives tracked by ExecPay. In other words, Clarke earned more than 19.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,263 out of 13,971 | 19th |
Division Manufacturing | 4,561 out of 5,698 | 20th |
Major group Chemicals And Allied Products | 1,795 out of 2,197 | 18th |
Industry group Drugs | 1,543 out of 1,883 | 18th |
Industry In Vitro and In Vivo Diagnostic Substances | 51 out of 77 | 34th |
Source: SEC filing on April 2, 2020.
Clarke's colleagues
We found three more compensation records of executives who worked with Anthony Clarke at OncoGenex Pharmaceuticals in 2019.